Skip to content Skip to footer
Menu Close
Close
Get in Touch
decor-image-8

OUR COMMITMENT

decor-image-6

Our company abides by the following unbreakable rules:

  1. Our main focus is to generate new cures for patients suffering from rare diseases caused by accelerated aging related to telomere attrition.
  2. All our resources and actions are aligned with this, including financial, personnel and timing ones.
  3. Our company will not pay any sort of dividend or pre-tax profit to any partner, board member or anybody else. All our pre-tax profits (this is, 100%) will be reinvested in the R&D needed to generate new cures for our patients.
  4. Our company does not provide company cars and/or personal credit cards to any staff member, board member, stockholder, subcontractor, etc. We dedicate all our resources to the R&D needed to generate new cures for our patients.
  5. When needed for travel, all our staff, board members and stockholders will fly commercial airlines economy class and will always use hotels with an average cost per night never higher than the average cost in the area. The same principle applies to any meal or other expenses needed during the trip.

6. Our Dermatology Division is focused on providing innovative products of excellence to treat psoriasis, acne, rosacea and other skin conditions, including those affecting people with Down Syndrome and other rare and non-rare derma conditions. All pre-tax profits (this is, 100%) from this division, will be reinvested in the needed R&D to generate new dermatology products and new drugs against the rare diseases we focus on.

7. All new business partners, staff members, personnel, executive members, managerial staff, stockholders and board members must commit in written to the full terms summarized here, with no exception whatsoever allowed.

8. Our company will reserve a % of all pre-tax profits to finance treatment for patients without the resources to get it through their normal health insurance, or health care system, independently of age or geographical location.

9. This commitment will stand as long as there is at least one remaining telomere-related rare disease with no cure or treatment, or an untreated patient, or a family with poor or no access to our medicines and treatments.